Ovid Therapeutics Inc.
09/16/2025 | Press release | Distributed by Public on 09/16/2025 06:01
Material Event (Form 8-K)
| Item 8.01 |
Other Events. |
On September 11, 2025, Ovid Therapeutics Inc., a Delaware corporation (the "Company"), received a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed companies maintain a minimum bid price of at least $1.00 per share, and that the matter is now closed.
Ovid Therapeutics Inc. published this content on September 16, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on September 16, 2025 at 12:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]